Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.68
-0.01 (-0.13%)
At close: Oct 30, 2025, 4:00 PM EDT
7.67
-0.01 (-0.13%)
Pre-market: Oct 31, 2025, 5:43 AM EDT
Kazia Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Kazia Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $16, which forecasts a 108.33% increase in the stock price over the next year. The lowest target is $13 and the highest is $20.
Price Target: $16 (+108.33%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +160.42% | Oct 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $13 | Strong Buy | Maintains | $2 → $13 | +69.27% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +95.31% | Jun 11, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +95.31% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +1,202.08% | Jul 12, 2024 |
Financial Forecast
Revenue This Year
68.34K
from 2.48M
Decreased by -97.25%
Revenue Next Year
51.00K
from 68.34K
Decreased by -25.37%
EPS This Year
-3.40
from -50.78
EPS Next Year
-1.87
from -3.40
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 70,350 | 105,000 | ||||
| Avg | 68,340 | 51,000 | ||||
| Low | 65,660 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -97.2% | 53.6% | ||||
| Avg | -97.2% | -25.4% | ||||
| Low | -97.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.50 | -1.92 | ||||
| Avg | -3.40 | -1.87 | ||||
| Low | -3.26 | -1.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.